• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定先天性厚甲症中有临床应用价值的预测性遗传变异。

Identification of clinically useful predictive genetic variants in pachyonychia congenita.

机构信息

Division of Dermatology, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel.

Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel.

出版信息

Clin Exp Dermatol. 2021 Jul;46(5):867-873. doi: 10.1111/ced.14569. Epub 2021 Mar 17.

DOI:10.1111/ced.14569
PMID:33486795
Abstract

BACKGROUND

Pachyonychia congenita (PC) refers to a group of autosomal dominant disorders caused by mutations in five keratin genes (KRT16,KRT6A,KRT17,KRT6B or KRT6C). Current disease classification is based on the gene harbouring disease-causing variants.

AIMS

We harnessed the International Pachyonychia Congenita Research Registry (IPCRR) containing both clinical and molecular data on patients with PC worldwide, to identify genetic variants predicting disease severity.

METHODS

We ascertained 815 individuals harbouring keratin mutations registered in the IPCRR. We looked for statistically significant associations between genetic variants and clinical manifestations in a subgroup of patients carrying mutations found in at least 10% of the cohort. Data were analysed using χ and Kruskal-Wallis tests.

RESULTS

We identified five mutations occurring in at least 10% of the patients registered in the IPCRR. The KRT16 p.L132P mutation was significantly associated with younger age of onset, presence of palmar keratoderma oral leucokeratosis and a higher number of involved nails. By contrast, the KRT16 p.N125S and p.R127C mutations resulted in a milder phenotype featuring a decreased number of involved nails and older age of onset. Patients carrying the p.N125S mutation were less likely to develop palmar keratoderma while p.R127C was associated with an older age of palmoplantar keratoderma onset. Moreover, the KRT17 p.L99P mutation resulted in an increased number of involved fingernails and patients demonstrating 20-nail dystrophy, while the opposite findings were observed with KRT17 p.N92S mutation.

CONCLUSIONS

We have identified novel and clinically useful genetic predictive variants in the largest cohort of patients with PC described to date.

摘要

背景

先天性厚甲症(PC)是一组常染色体显性遗传疾病,由五个角蛋白基因(KRT16、KRT6A、KRT17、KRT6B 或 KRT6C)的突变引起。目前的疾病分类基于携带致病变异的基因。

目的

我们利用包含全球 PC 患者临床和分子数据的国际先天性厚甲症研究注册处(IPCRR),确定预测疾病严重程度的遗传变异。

方法

我们确定了在 IPCRR 中注册的携带角蛋白突变的 815 个人。我们在携带至少 10%队列中发现的突变的患者亚组中,寻找遗传变异与临床表现之间的统计学显著关联。数据使用 χ 和 Kruskal-Wallis 检验进行分析。

结果

我们确定了在 IPCRR 中注册的至少 10%患者中发生的五个突变。KRT16 p.L132P 突变与发病年龄较小、手掌角化过度、口腔白角化病和受累指甲数量较多显著相关。相比之下,KRT16 p.N125S 和 p.R127C 突变导致受累指甲数量减少和发病年龄较大的轻度表型。携带 p.N125S 突变的患者发生手掌角化过度的可能性较小,而 p.R127C 与掌跖角化过度发病年龄较大相关。此外,KRT17 p.L99P 突变导致受累指甲数量增加,患者表现为 20 指甲营养不良,而 KRT17 p.N92S 突变则相反。

结论

我们在迄今为止描述的最大 PC 患者队列中确定了新的、具有临床意义的遗传预测变异。

相似文献

1
Identification of clinically useful predictive genetic variants in pachyonychia congenita.鉴定先天性厚甲症中有临床应用价值的预测性遗传变异。
Clin Exp Dermatol. 2021 Jul;46(5):867-873. doi: 10.1111/ced.14569. Epub 2021 Mar 17.
2
Revisiting pachyonychia congenita: a case-cohort study of 815 patients.再探先天性厚甲症:一项针对815例患者的病例队列研究。
Br J Dermatol. 2020 Mar;182(3):738-746. doi: 10.1111/bjd.18794. Epub 2020 Jan 14.
3
The molecular genetic analysis of the expanding pachyonychia congenita case collection.先天性厚甲症病例集扩充的分子遗传学分析
Br J Dermatol. 2014 Aug;171(2):343-55. doi: 10.1111/bjd.12958. Epub 2014 Aug 6.
4
Pachyonychia congenita patients with mutations in KRT6A have more extensive disease compared with patients who have mutations in KRT16.先天性厚甲症患者中,KRT6A 基因突变者的疾病比 KRT16 基因突变者更为广泛。
Br J Dermatol. 2012 Apr;166(4):875-8. doi: 10.1111/j.1365-2133.2011.10745.x.
5
A review of the clinical phenotype of 254 patients with genetically confirmed pachyonychia congenita.254 例遗传性先天性厚甲症患者的临床表型综述。
J Am Acad Dermatol. 2012 Oct;67(4):680-6. doi: 10.1016/j.jaad.2011.12.009. Epub 2012 Jan 20.
6
Two novel de novo mutations of KRT6A and KRT16 genes in two Chinese pachyonychia congenita pedigrees with fissured tongue or diffuse plantar keratoderma.两个中国先天性厚甲症家系中存在 KRT6A 和 KRT16 基因突变,伴有裂舌或弥漫性跖部角化过度。
Eur J Dermatol. 2012 Jul-Aug;22(4):476-80. doi: 10.1684/ejd.2012.1773.
7
A large mutational study in pachyonychia congenita.大样本先天性厚甲症基因突变研究。
J Invest Dermatol. 2011 May;131(5):1018-24. doi: 10.1038/jid.2011.20. Epub 2011 Feb 17.
8
Phenotype and genotype features of Vietnamese children with pachyonychia congenita.越南先天性厚甲症患儿的表型和基因型特征
Pediatr Neonatol. 2023 Jul;64(4):405-410. doi: 10.1016/j.pedneo.2022.09.018. Epub 2023 Jan 3.
9
Pachyonychia congenita: a case report of a successful treatment with rosuvastatin in a patient with a KRT6A mutation.先天性厚甲症:一例 KRT6A 突变患者使用瑞舒伐他汀成功治疗的病例报告。
Br J Dermatol. 2019 Sep;181(3):584-586. doi: 10.1111/bjd.17276. Epub 2018 Dec 2.
10
First case of pachyonychia congenita in the Czech Republic.捷克共和国先天性厚甲症首例病例。
Dermatol Ther. 2015 Jan-Feb;28(1):10-2. doi: 10.1111/dth.12142. Epub 2014 Aug 29.

引用本文的文献

1
Clinical and Genetic Findings in Patients With Palmoplantar Keratoderma.掌跖角化病患者的临床及遗传学发现
JAMA Dermatol. 2025 Feb 1;161(2):157-166. doi: 10.1001/jamadermatol.2024.4824.
2
Coexistence of pachyonychia congenita and hidradenitis suppurativa: more than a coincidence.先天性厚甲症和化脓性汗腺炎共存:不仅仅是巧合。
Br J Dermatol. 2022 Sep;187(3):392-400. doi: 10.1111/bjd.21674. Epub 2022 Jun 17.